Using GEPIA, we determined that that ERO1α is considered a bad prognostic indicator in multiple cancer indications including Lung Adenocarcinoma, Hepatocellular Carcinoma, Esophageal Carcinoma, and Diffuse B-Cell Lymphoma (see Figure 3 and Table 1). The gene discussed is ERO1A; the disease is cancer.